Patents by Inventor Steven Kerrigan

Steven Kerrigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082347
    Abstract: Use of a ?V?3 integrin antagonist, such as cilengitide or a functional variant thereof, for the treatment or prevention of a disease caused by a coronavirus is described, particularly, in which cilengitide is delivered to the subject intravenously or orally.
    Type: Application
    Filed: January 21, 2022
    Publication date: March 14, 2024
    Applicant: ROYAL COLLEGE OF SURGEONS IN IRELAND
    Inventors: Steven KERRIGAN, Danlelle NADER
  • Publication number: 20190105366
    Abstract: Use of a ?V?3 antagonist such as cilengitide or a functional variant thereof for the treatment or prevention of sepsis in a patient is described, in which the cilengitide is delivered to the patient intravenously.
    Type: Application
    Filed: February 17, 2017
    Publication date: April 11, 2019
    Inventor: Steven Kerrigan